Tag: Prescription Drugs
For Those With Heart Failure, ACE2 Concentrations Up in Men
Use of ACE inhibitors, ARBs not tied to higher plasma ACE2 concentrations in those with heart failure
Anakinra May Reduce Systemic Inflammation in COVID-19
At 21 days, survival was 90 percent in anakinra group versus 56 percent in standard treatment group
Triple Antiviral Therapy Promising for Mild-to-Moderate COVID-19
Duration of viral shedding shorter with combination of lopinavir-ritonavir, ribavarin, interferon beta-1b
Hydroxychloroquine Has No Impact on Outcomes in COVID-19
No link seen between use of the drug and risk for composite end point of intubation or death
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
No significant association identified in overlap propensity score weighting analysis
Asthma, COPD Medication Adherence Up During Pandemic
Authors say increased adherence may reflect patient concern about controlling primary respiratory illness
CDC: Prevalence of Hypertension Higher in Rural Versus Urban Areas
HTN prevalence varied from 18.0 to 55.0 percent across counties; med use also higher in rural areas
RHB-105 Effective for Eradication of Helicobacter pylori in Adults
Eradication rates with triple therapy unaffected by resistance to clarithromycin, metronidazole
Endovascular Thrombectomy Alone Noninferior in Ischemic Stroke
Noninferior to IV alteplase followed by endovascular thrombectomy for acute ischemic stroke
ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
